Leveraging patient-derived cutaneous neurofibroma organoid models to identify biomarkers of drug response

syn51301409

Created By NF Service nf-osi-service

grantDOI: https://doi.org/10.54464/pc.gr.160969
studyName: Leveraging patient-derived cutaneous neurofibroma organoid models to identify biomarkers of drug response
dataStatus: Data Pending
initiative: Biology and Therapeutic Development for Cutaneous Neurofibromas
studyLeads: Alice Soragni Sara Gosline
studyStatus: Active
diseaseFocus: Neurofibromatosis type 1
institutions: University of California, Los Angeles Pacific Northwest National Laboratory
fundingAgency: NTAP
relatedStudies: syn51116567 syn11374354 syn4939892 syn4939910
studyFileviewId: syn51301431
syn51301410
syn53164954
syn51301411
syn51301431
syn51301412

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

Leveraging patient-derived cutaneous neurofibroma organoid models to identify biomarkers of drug response

syn51301409

Drop files to upload

Leveraging patient-derived cutaneous neurofibroma organoid models to identify biomarkers of drug response page is loading…